Stroke prevention in atrial fibrillation: update with NOAC treatment and the impact of reversal

by Ket Patel | Dec 21, 2018 | Uncategorized

Results from RCTs and real-world analyses consistently demonstrate the safety and efficacy profiles of dabigatran in patients with atrial fibrillation.

Improving stroke care across the world: the Angels Initiative

by Ket Patel | Dec 21, 2018 | Uncategorized

Stroke is today one of the leading causes of death and, after dementia – often caused by a previous stroke – the 2nd leading cause of disability globally, and the burden of stroke is increasing.

The ANGELS Initiative: More and better Stroke-ready hospitals across the globe

by Ket Patel | Dec 21, 2018 | Uncategorized

Established by Boehringer Ingelheim in 2015, in collaboration with international stroke experts and the European Stroke Organisation (ESO), the Acute Networks StrivinG for ExceLlence in Stroke (ANGELS) project has had a major impact on expanding available treatment...

Innovations in Endovascular Treatment of Acute Ischemic Stroke and Cerebral Aneurysms

by Ket Patel | Dec 21, 2018 | Uncategorized

Technological innovations are optimizing endovascular treatment of patients with acute ischemic stroke (AIS) and cerebral aneurysms.

Clinical Outcomes and Work Flow Optimisation with Pipeline System and Shield Technology

by Ket Patel | Dec 21, 2018 | Uncategorized

Endovascular treatment is the treatment of choice for many intracerebral aneurysms (ICAs). However, coiling is probably less effective for giant or wide-necked aneurysms, and retreatment is not uncommon. Flow diversion (FD) is a novel endovascular approach to ICA...